Jump to Content

Centre for Drug Formulation and Delivery

Centre for Drug Formulation and DeliveryThe Centre for Drug Formulation and Delivery (CDF&D) is an educational, research and pharmaceutical production facility based at UniSA's Sansom Institute for Health Research. It is part of the Institute's Therapeutics and Pharmaceutical Science research concentration.

Established in 2007, the CDF&D aims to harness South Australia's pharmaceutical science expertise to become a world leader in the development of novel drug delivery technologies.

The Centre boasts a new purpose-built laboratory with pilot-scale pharmaceutical manufacturing equipment that provides UniSA researchers and Bachelor of Pharmaceutical Science students access to state-of-the-art facilities to match industry standards.

With support from government and the pharmaceutical and biotechnology sectors, the CDFD is involved in collaborative projects, developing new products technologies with the ultimate aim of improving human health.

People
Projects
Collaborators
Publications
Contract services
Contact

People

Key staff

Dr May Song - formulation scientist
Frank Peddie - adjunct senior research fellow
Professor Allan Evans - PVC and senior advisor
Professor Michael Roberts - consultant
Associate Professor Bob Milne - consultant
Dr Des Williams - consultant
Dr Andrew Davey - consultant

Postgraduate students

Shasha Rao

CDFD advisory board

The CDFD advisory board - which includes representatives from UniSA's Sansom Institute and Ian Wark Research Institute, the Royal Adelaide Hospital and the pharmaceutical industry - meets three times a year to review progress and recommend strategic initiatives.

Advisory board members include:

Industry representatives:

Projects

The CDFD is involved in various University, government and industry-funded projects aimed at developing better pharmaceutical products and drug delivery technologies.

Some of our current projects include:

Collaborators

The CDFD enjoys productive relationships with a number of collaborators and clients including:

Recent publications

CDFD researchers are indicated in bold

1. Jie Zhuang,Qineng Ping, Yunmei Song,Jianping Qi, Zheng Cui, Effects of chitosan coating on physical properties and pharmacokinetic behaviour of mitoxantrone liposomes. International Journal of Nanomedicine. 2010, 5: 407-416;

2. Spomenka Simovic, He Hui, Yunmei Song, Andrew K. Davey, Thomas Rades, Clive A. Prestidge, An oral delivery system for indomethicin engineered from cationic lipid emulsions and silica nanoparticles, Journal of Controlled Release. 2010, 143:367-373;

3.Jianping Qi, Minjie Sun, Qineng Ping, Jie Zhuang, Jiangran Li, Frank Peddie, Yunmei Song. The mechanisms for enhanced oral absorption of hydroxysafflor yellow a by chuanxiong volatile oil. Planta Medica. 2010, 76(8):786-92;

4. Spomenka Simovic, Peter Heard, He Hui, Yunmei Song, Frank Peddie, Andrew Davey, Andrew Lewis and Clive A. Prestidge. Dry hybrid capsules engineered from submicron lipid droplets and nanoparticles. Mol Pharm. 2009, 6(3):861-72;

5. Yunmei Song, Jie Zhuang, Yanyu Xiao, Qineng Ping. Preparation of silybin-phospholipid complex and study on its properties. Pharmazie. 2008, 63(1):35-42;

6. Prestidge, CA, Barnes, TJ, Mierczynska-Vasilev, A, Kempson, I, Peddie, F and Barnett, C, 'Peptide and protein loading into porous silicon wafers' Phys. Stat. Sol. (a), 2008, 205(2), 311-315;

7. Prestidge CA, Barnes TJ, Mierczynska-Vasilev A, Skinner W, Peddie F, Lau CH and Barnett C, Loading and release of a model protein from porous silicon powders Phys. Stat. Sol. (a), 2007,204(10), 3361-3366.

Contract services

The CDFD offers contract research and development services (particularly in drug formulation and development), with specific expertise in:

1. Formulation development and preparation of novel systems for delivering active substances (Applications may include human pharmaceutical or veterinary use, and also controlled release of gases, chemicals or other agents into a wide range of environments.)

2. Drug quality evaluations, including in vitro and in vivo studies

3. In-vivo animal toxicity trials, pharmacokinetic and pharmacodynamic studies

4. Analytical services

5. In-vivo Phase I & II clinical trials (in conjunction with the CPR)

6. Collaborative R&D with access to government funding schemes (e.g. ARC Linkage or NH&MRC Grants, AusIndustry Commercial Ready Grants for Industry.)

Contact

For more information on the Centre for Drug Formulation and Delivery, please contact May Song on:
phone: +61 8 8302 2429
fax: +61 8 8302 1087
email: may.song@unisa.edu.au

top^